SGT-003
SGT-003-101
Phase 3 gene_therapy active
Quick answer
SGT-003 for Duchenne Muscular Dystrophy is a Phase 3 program (gene_therapy) at Solid Biosciences with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Solid Biosciences
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Phase 3
- Modality
- gene_therapy
- Status
- active